BR112012012108A2 - composição farmacêutica compreendendo propofol - Google Patents
composição farmacêutica compreendendo propofolInfo
- Publication number
- BR112012012108A2 BR112012012108A2 BR112012012108A BR112012012108A BR112012012108A2 BR 112012012108 A2 BR112012012108 A2 BR 112012012108A2 BR 112012012108 A BR112012012108 A BR 112012012108A BR 112012012108 A BR112012012108 A BR 112012012108A BR 112012012108 A2 BR112012012108 A2 BR 112012012108A2
- Authority
- BR
- Brazil
- Prior art keywords
- propofol
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C19/00—Acyclic saturated compounds containing halogen atoms
- C07C19/08—Acyclic saturated compounds containing halogen atoms containing fluorine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09014548A EP2332525A1 (en) | 2009-11-23 | 2009-11-23 | Pharmaceutical composition comprising propofol |
| PCT/EP2010/067938 WO2011061332A1 (en) | 2009-11-23 | 2010-11-22 | Pharmaceutical composition comprising propofol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012012108A2 true BR112012012108A2 (pt) | 2016-04-05 |
Family
ID=41694756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012012108A BR112012012108A2 (pt) | 2009-11-23 | 2010-11-22 | composição farmacêutica compreendendo propofol |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8796340B2 (OSRAM) |
| EP (2) | EP2332525A1 (OSRAM) |
| JP (1) | JP5707009B2 (OSRAM) |
| KR (1) | KR20120104262A (OSRAM) |
| CN (1) | CN102753159B (OSRAM) |
| AU (1) | AU2010320823B2 (OSRAM) |
| BR (1) | BR112012012108A2 (OSRAM) |
| CA (1) | CA2776855C (OSRAM) |
| ES (1) | ES2450423T3 (OSRAM) |
| IN (1) | IN2012DN03130A (OSRAM) |
| MX (1) | MX2012005881A (OSRAM) |
| WO (1) | WO2011061332A1 (OSRAM) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101656121B1 (ko) | 2010-03-17 | 2016-09-08 | 노바리크 게엠베하 | 안압 증가를 치료하기 위한 약학 조성물 |
| EP2444063A1 (en) | 2010-10-20 | 2012-04-25 | Novaliq GmbH | Liquid pharmaceutical compositions for the delivery of active ingredients |
| EP2462921A1 (en) | 2010-11-11 | 2012-06-13 | Novaliq GmbH | Liquid pharmaceutical compositions for the treatment of a posterior eye disease |
| EP2714008B1 (en) | 2011-05-25 | 2016-12-14 | Novaliq GmbH | Pharmaceutical composition for administration to nails |
| PT2714010T (pt) | 2011-05-25 | 2017-05-05 | Novaliq Gmbh | Composição farmacêutica tópica à base de alcanos semifluorados |
| GB201116271D0 (en) | 2011-09-21 | 2011-11-02 | Univ Cardiff | Dispersion anaesthetic device |
| CA2862974C (en) | 2012-01-23 | 2021-11-16 | Novaliq Gmbh | Stabilised protein compositions based on semifluorinated alkanes |
| CA2883003C (en) | 2012-09-12 | 2021-11-16 | Novaliq Gmbh | Semifluorinated alkane compositions |
| EP2708228B1 (en) * | 2012-09-12 | 2018-05-16 | Novaliq GmbH | Eye wash compositions |
| CN113679697A (zh) | 2012-09-12 | 2021-11-23 | 诺瓦利克有限责任公司 | 包含半氟化烷烃的混合物的组合物 |
| ES2687094T3 (es) | 2013-07-23 | 2018-10-23 | Novaliq Gmbh | Composiciones estabilizadas de anticuerpos |
| EP2944324A1 (de) * | 2014-05-13 | 2015-11-18 | LTS LOHMANN Therapie-Systeme AG | Verwendung von semifluorierten Alkanen in transdermalen therapeutischen Systemen |
| JP2017531011A (ja) | 2014-10-16 | 2017-10-19 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | 麻酔のための新規の方法、化合物および組成物 |
| DE202016008738U1 (de) | 2015-09-30 | 2019-04-09 | Novaliq Gmbh | Semifluorierte Verbindungen und ihre Zusammensetzungen |
| DK3722274T3 (da) | 2015-09-30 | 2023-09-11 | Novaliq Gmbh | 2-perfluorbutylpentan til oftalmisk indgivelse |
| ES2763121T3 (es) | 2016-06-23 | 2020-05-27 | Novaliq Gmbh | Método de administración tópica |
| CA3036297C (en) | 2016-09-22 | 2023-09-05 | Novaliq Gmbh | Pharmaceutical compositions for use in the therapy of blepharitis |
| US10813976B2 (en) | 2016-09-23 | 2020-10-27 | Novaliq Gmbh | Ophthalmic compositions comprising ciclosporin |
| ES2965883T3 (es) | 2016-12-23 | 2024-04-17 | Novaliq Gmbh | Composición oftálmica para el tratamiento de la enfermedad del ojo seco |
| WO2018193093A1 (en) | 2017-04-21 | 2018-10-25 | Novaliq Gmbh | Iodine compositions |
| US11278503B2 (en) | 2017-05-12 | 2022-03-22 | Novaliq Gmbh | Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions |
| CA3076776A1 (en) | 2017-09-27 | 2019-04-04 | Novaliq Gmbh | Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases |
| CN120022260A (zh) | 2017-10-04 | 2025-05-23 | 诺瓦利克有限责任公司 | 包含f6h8的眼用组合物 |
| WO2019166631A1 (en) | 2018-03-02 | 2019-09-06 | Novaliq Gmbh | Pharmaceutical compositions comprising nebivolol |
| EP3784246A1 (en) | 2018-04-27 | 2021-03-03 | Novaliq GmbH | Ophthalmic compositions comprising tafluprost for the treatment of glaucoma |
| JP7360452B2 (ja) | 2018-09-27 | 2023-10-12 | ダーマリック セラピューティクス， インコーポレーテッド | 脂質バリアの修復 |
| AU2019358249B2 (en) | 2018-10-12 | 2024-02-22 | Novaliq Gmbh | Ophthalmic composition for treatment of dry eye disease |
| EP3923907B1 (en) | 2019-02-13 | 2024-09-25 | Novaliq GmbH | Compositions and methods for the treatment of ocular neovascularization |
| KR20220058577A (ko) | 2019-09-06 | 2022-05-09 | 노바리크 게엠베하 | 포도막염 치료를 위한 안과용 조성물 |
| EP3912622A1 (en) | 2020-05-19 | 2021-11-24 | tesa Labtec GmbH | Oral film for safe administration of api |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5496537A (en) * | 1995-03-23 | 1996-03-05 | Henry; Richard A. | Propofol hydrofluorocarbon propellant formulations |
| DE19536504C2 (de) | 1995-09-29 | 1999-09-23 | H Meinert | Verwendung fluorierter Alkane |
| AU3898700A (en) * | 1999-03-15 | 2000-10-04 | John Claude Krusz | Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages |
| GB0124071D0 (en) * | 2001-10-08 | 2001-11-28 | Kbig Ltd | Improvement in the administration of high boiling point aneasthetics |
| EP1732485A2 (en) * | 2004-01-02 | 2006-12-20 | Wisconsin Alumni Research Foundation | Encapsulation of chemical compounds in fluorous-core and fluorous-inner-shell micelles formed from semifluorinated-block or fluorinated-block copolymers |
| DE102004030044A1 (de) | 2004-06-22 | 2006-01-12 | Birken Gmbh | Triterpenhaltiger Oleogelbildner, triterpenhaltiges Oleogel und Verfahren zur Herstellung eines triterpenhaltigen Oleogels |
| WO2008070490A2 (en) * | 2006-11-28 | 2008-06-12 | Wisconsin Alumni Research Foundation | Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics |
| DK2110126T3 (da) | 2008-04-18 | 2012-02-27 | Novaliq Gmbh | Inhalations- og instillationsanvendelse af semifluorerede alkaner som aktiv bestanddel-bærere inden for det intrapulmonale område |
-
2009
- 2009-11-23 EP EP09014548A patent/EP2332525A1/en not_active Withdrawn
-
2010
- 2010-11-22 BR BR112012012108A patent/BR112012012108A2/pt not_active Application Discontinuation
- 2010-11-22 ES ES10778677.4T patent/ES2450423T3/es active Active
- 2010-11-22 CA CA2776855A patent/CA2776855C/en active Active
- 2010-11-22 IN IN3130DEN2012 patent/IN2012DN03130A/en unknown
- 2010-11-22 KR KR1020127016348A patent/KR20120104262A/ko not_active Withdrawn
- 2010-11-22 CN CN201080052400.7A patent/CN102753159B/zh active Active
- 2010-11-22 WO PCT/EP2010/067938 patent/WO2011061332A1/en not_active Ceased
- 2010-11-22 US US13/511,184 patent/US8796340B2/en active Active
- 2010-11-22 MX MX2012005881A patent/MX2012005881A/es not_active Application Discontinuation
- 2010-11-22 JP JP2012539355A patent/JP5707009B2/ja active Active
- 2010-11-22 AU AU2010320823A patent/AU2010320823B2/en active Active
- 2010-11-22 EP EP10778677.4A patent/EP2503999B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010320823B2 (en) | 2014-06-26 |
| JP5707009B2 (ja) | 2015-04-22 |
| EP2503999B1 (en) | 2013-12-25 |
| MX2012005881A (es) | 2012-06-19 |
| EP2332525A1 (en) | 2011-06-15 |
| EP2503999A1 (en) | 2012-10-03 |
| IN2012DN03130A (OSRAM) | 2015-09-18 |
| US20120238639A1 (en) | 2012-09-20 |
| KR20120104262A (ko) | 2012-09-20 |
| CA2776855C (en) | 2017-10-24 |
| CN102753159A (zh) | 2012-10-24 |
| CN102753159B (zh) | 2014-03-12 |
| AU2010320823A1 (en) | 2012-07-12 |
| US8796340B2 (en) | 2014-08-05 |
| WO2011061332A1 (en) | 2011-05-26 |
| JP2013511496A (ja) | 2013-04-04 |
| CA2776855A1 (en) | 2011-05-26 |
| ES2450423T3 (es) | 2014-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012012108A2 (pt) | composição farmacêutica compreendendo propofol | |
| DK3097925T3 (da) | Farmaceutisk sammensætning | |
| BRPI1004940A2 (pt) | composição farmacêutica | |
| SMT201700095B (is) | Composizioni farmaceutiche per inalazione | |
| SMT201700008B (it) | Composizione farmaceutica | |
| BRPI1012539A2 (pt) | composições farmacêuticas | |
| SMT201600350B (it) | Composizioni farmaceutiche | |
| LT3061445T (lt) | Labai koncentruotos farmacinės kompozicijos | |
| SMT201600307B (it) | Composizione liposomiale | |
| BRPI1015939A2 (pt) | composição farmacêutica | |
| DK3246018T3 (da) | Farmaceutisk sammensætning | |
| BRPI1013588A2 (pt) | composição | |
| EP2451274A4 (en) | Pharmaceutical compositions | |
| BRPI1015474A2 (pt) | composição | |
| IT1394400B1 (it) | Composizioni farmaceutiche | |
| DK2285413T3 (da) | Farmaceutisk sammensætning | |
| DK2391349T3 (da) | Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater | |
| EE201300005A (et) | Ravimkoostis | |
| EP2236149A4 (en) | MEDICAL COMPOSITION | |
| BRPI0921313A2 (pt) | composição farmaucêutica | |
| BR112012000831A2 (pt) | compostos, composições farmacêuticas e métodos relacionados | |
| CO6801722A2 (es) | Composiciones farmacéuticas | |
| BRPI1005290A2 (pt) | composição | |
| EP2394634A4 (en) | COMPOSITION CONTAINING HESPERIDINE | |
| BR112012003149A2 (pt) | composição farmacêutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |